annb0t
Top 20
AFT Pharmaceuticals Limited (NZSE:AFT) shareholders might be concerned after seeing the share price drop 12% in the last quarter. But don't let that distract from the very nice return generated over three years. In the last three years the share price is up, 62%: better than the market.
With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.
Check out our latest analysis for AFT Pharmaceuti...
>>> Read more: Investing in AFT Pharmaceuticals (NZSE:AFT) three years ago would have delivered you a 62% gain
With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.
Check out our latest analysis for AFT Pharmaceuti...
>>> Read more: Investing in AFT Pharmaceuticals (NZSE:AFT) three years ago would have delivered you a 62% gain
